|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contact |
26 Gaoneng Street, Room 405,
Dalian High-tech Zone,
Dalian, LN 116025, China
|
|
|
|
|
|
| Description |
The 1st World Congress of Virus and Infections is the extension of the previous two annual World Summits of Antivirals. There are 3 parallel symposia at this congress: 1st World Congress of Virus and Infections, 1st Annual Inaugurate Symposium of Hepatitis Virus and 3rd Annual World Summit of Antivirals. WCVI 2010 will set World Summit of Antivirals as the essence, arrange a unique symposium for hepatitis virus and enlarge its involvement in animal and plant antivirals. There is also a large poster session arranged for young scientists to have them heard by the worldwide professionals.
|
|
| Additional Information |
Highlights:
3 Parallel sub-conferences of more than 150 remarkable sessions
1000 scientific and technological posters to share the new findings and breakthroughs
500-800 parallel presentations and discussions on update current novel R & D status
100-150 exhibitors to demonstrate their products and technology development
100 Showcases for most promising and fast growing companies in antiviral R & D
Special tailored 1 to 1 network for business and collaboration demands.
Name of Tracks:
WCVI
Track 1: Global Epidemics and Prevention
Track 2: General Virology and Basic Sciences
Track 3: Medical and Clinical Virology
Track 4: Retrovirus-HIV/AIDS-Basic Sciences and Implications
Track 5: Other Retrovirus Researches
Track 6: Respiratory and Emerging/Re-emerging Viruses
Track 7: Neuro-Viorology
Track 8: Pediatric Viral Infectious Diseases
Track 9: Human Tumor Virology
Track 10: Viral Immunology, Infection and Immunity
Track 11: Agriculture and Plant Virology
Track 12: Veterinary Virology
SHV
Track 1: Hepatitis A and E Virus
Track 2: Hepatitis B and D Virus
Track 3: Hepatisis C Virus
Track 4: Virus and Liver Cancer
WSA
Track 1: Targeting Drug Discovery and Development-Small Molecules
Track 2: Antiviral Vaccine Development
Track 3: Immunotherapy and Therapeutic Antibodies
Track 4: Gene Therapy for Viral Infections
|
|
